BEVACIZUMAB AND FOTEMUSTINE AS SALVAGE THERAPY IN RECURRENT GLIOBLASTOMA: A PHASE II MULTICENTER ITALIAN STUDY

被引：0
|
作者：
Trevisan, E. [1 ]
Ruda, R. [1 ]
Picco, E. [1 ]
Crasto, S. Greco [2 ]
Caroli, M. [3 ]
Fabrini, A. [4 ]
Scotti, V. [4 ]
Lolli, I.
Guarneri, D. [1 ]
Soffietti, R. [1 ]
机构：
[1] Neurooncol Dept, Turin, Italy
[2] Dept Radiol, Turin, Italy
[3] Dept Neurosurg, Turin, Italy
[4] Dept Radiotherapy, Pisa, Italy
来源：
NEURO-ONCOLOGY | 2010年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：49 / 50
页数：2
相关论文
共 50 条
  • [41] Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy
    Reardon, David A.
    Desjardins, Annick
    Peters, Katherine B.
    Vredenburgh, James J.
    Gururangan, Sridharan
    Sampson, John H.
    McLendon, Roger E.
    Herndon, James E., II
    Coan, April
    Threatt, Stevie
    Friedman, Allan H.
    Friedman, Henry S.
    CANCER, 2011, 117 (23) : 5351 - 5358
  • [42] Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma
    Lee, Eudocia Q.
    Reardon, David A.
    Schiff, David
    Drappatz, Jan
    Muzikansky, Alona
    Grimm, Sean A.
    Norden, Andrew D.
    Nayak, Lakshmi
    Beroukhim, Rameen
    Rinne, Mikael L.
    Chi, Andrew S.
    Batchelor, Tracy T.
    Hempfling, Kelly
    McCluskey, Christine
    Smith, Katrina H.
    Gaffey, Sarah C.
    Wrigley, Brendan
    Ligon, Keith L.
    Raizer, Jeffrey J.
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2015, 17 (06) : 862 - 867
  • [43] SAFETY AND EFFICACY OF BEVACIZUMAB AND ERLOTINIB FOR RECURRENT GLIOBLASTOMA PATIENTS IN A PHASE II STUDY
    Sathornsumetee, Sith
    Desjardins, Annick
    Vredenburgh, James
    Rich, Jeremy
    Gururangan, Sridharan
    Friedman, Allan
    Friedman, Henry
    Reardon, David
    NEURO-ONCOLOGY, 2008, 10 (05) : 827 - 827
  • [44] A randomized phase II study of carboplatin and bevacizumab in recurrent glioblastoma multiforme (CABARET)
    Field, Kathryn Maree
    Simes, John
    Wheeler, Helen
    Hovey, Elizabeth J.
    Nowak, Anna K.
    Cher, Lawrence
    Brown, Chris
    Livingstone, Ann
    Sawkins, Kate
    Rosenthal, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] RTOG 0625: A phase II study of bevacizumab with irinotecan in recurrent glioblastoma (GBM)
    Gilbert, M. R.
    Wang, M.
    Aldape, K.
    Lassman, A.
    Sorensen, A. G.
    Mikkelson, T.
    Groves, M.
    Werner-Wasik, M.
    Regine, W.
    Mehta, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] A RANDOMIZED PHASE II STUDY OF CARBOPLATIN AND BEVACIZUMAB IN RECURRENT GLIOBLASTOMA MULTIFORME ( CABARET STUDY)
    Field, Kathryn M.
    Cher, Lawrence
    Wheeler, Helen
    Hovey, Elizabeth
    Nowak, Anna K.
    Simes, John
    Sawkins, Kate
    France, Trevor
    Brown, Chris
    NEURO-ONCOLOGY, 2011, 13 : 88 - 88
  • [47] A RANDOMISED PHASE II STUDY OF CARBOPLATIN AND BEVACIZUMAB IN RECURRENT GLIOBLASTOMA MULTIFORME (CABARET STUDY)
    Field, K. M.
    Rosenthal, M. A.
    Wheeler, H.
    Cher, L.
    Hovey, E.
    Nowak, A. K.
    Brown, C.
    Livingstone, A.
    Sawkins, K.
    Simes, J.
    NEURO-ONCOLOGY, 2012, 14 : 41 - 41
  • [48] A RANDOMISED PHASE II STUDY OF CARBOPLATIN AND BEVACIZUMAB IN RECURRENT GLIOBLASTOMA MULTIFORME (CABARET STUDY)
    Field, Kathryn M.
    Simes, John
    Nowak, Anna K.
    Hovey, Elizabeth
    Wheeler, Helen
    Cher, Lawrence
    Brown, Chris
    Livingstone, Ann
    Sawkins, Kate
    Rosenthal, Mark A.
    NEURO-ONCOLOGY, 2012, 14 : 101 - 102
  • [49] Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma
    Clarke, Jennifer
    Neil, Elizabeth
    Terziev, Robert
    Gutin, Philip
    Barani, Igor
    Kaley, Thomas
    Lassman, Andrew B.
    Chan, Timothy A.
    Yamada, Josh
    DeAngelis, Lisa
    Ballangrud, Ase
    Young, Robert
    Panageas, Katherine S.
    Beal, Kathryn
    Omuro, Antonio
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (04): : 797 - 804
  • [50] A multi-institutional phase II study on second-line Fotemustine chemotherapy in recurrent glioblastoma
    Maria Grazia Fabrini
    Giovanni Silvano
    Ivan Lolli
    Franco Perrone
    Annarita Marsella
    Valerio Scotti
    Luca Cionini
    Journal of Neuro-Oncology, 2009, 92
12345